Fundraising Fox
ADC Therapeutics SA
NYSE: ADCTIncorporated in Switzerland · 3 known investors
Find your way into ADC Therapeutics SA
3,471 people in our graph can introduce you to the ADC Therapeutics SA team.
Sign up to see every warm intro you have to ADC Therapeutics SA
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ADC Therapeutics SA team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology. It operates in the biotech and pharmaceutical industry.
Founders & leadership
AM
Ameet MallikChief Executive OfficerAmeet Mallik is Chief Executive Officer of ADC Therapeutics, a biopharmaceutical company developing antibody drug conjugates for hematologic and oncologic indications. He previously served as CEO of Rafael Holdings, held leadership roles spanning oncology and pharma during 16+ years at Novartis including Executive Vice President of US Oncology, and worked as an Associate Principal at McKinsey & Company; he holds an MBA from Wharton and master's and bachelor's degrees in biotechnology and chemical engineering from Northwestern University.
JC
Jose CarmonaChief Financial Officer
KH
Kristen Harrington-SmithChief Commercial OfficerKristen Harrington-Smith is Chief Commercial Officer at ADC Therapeutics, a biopharmaceutical company developing antibody drug conjugates for hematology and oncology. She has held leadership roles in pharmaceutical product launches and commercialization across multiple therapeutic areas including hematology, oncology, cell and gene therapies, neuroscience, and cardiovascular disease.
DE
David EgeChief Technical OfficerDavid Ege is Chief Technical Officer at ADC Therapeutics, overseeing manufacturing operations and quality for its antibody drug conjugate therapies. He has over 20 years of pharmaceutical and biotech experience in biologics and vaccines manufacturing, including roles at Merck where he contributed to the development and launch of Gardasil, Gardasil9, and Keytruda, and at Seres Therapeutics where he worked on VOWST's approval.
PG
Peter GrahamChief Legal OfficerPeter Graham is Chief Legal Officer at ADC Therapeutics, a biopharmaceutical company developing antibody drug conjugates for hematology and oncology. He has held senior legal and compliance roles at publicly and privately held medical device, pharmaceutical, and life sciences companies, with expertise spanning regulatory affairs, corporate governance, M&A, and intellectual property.
KP
Kimberly PopeChief People Officer
Investors · 3
Related companies · 9
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
PublicPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
AlumniAstraZeneca develops and markets pharmaceutical products, vaccines, and biologics across oncology, cardiovascular disease, respiratory and immunology, and rare disease areas, serving patients and healthcare providers globally.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
TipRanksFinancial analysis and stock research platform.
Companies working in the same space as ADC Therapeutics SA.
Frequently asked questions
- What does ADC Therapeutics SA do?
- ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology. It operates in the biotech and pharmaceutical industry.
- Who are ADC Therapeutics SA's investors?
- ADC Therapeutics SA's investors include ETCapital, HEALTHCARE ROYALTY PARTNERS, Scientia Ventures.